245 related articles for article (PubMed ID: 35939049)
1. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
Monteleone S; Fedorov DG; Townsend-Nicholson A; Southey M; Bodkin M; Heifetz A
J Chem Inf Model; 2022 Aug; 62(16):3784-3799. PubMed ID: 35939049
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Protein-Protein Interactions with the Fragment Molecular Orbital Method.
Heifetz A; Sladek V; Townsend-Nicholson A; Fedorov DG
Methods Mol Biol; 2020; 2114():187-205. PubMed ID: 32016895
[TBL] [Abstract][Full Text] [Related]
3. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
[TBL] [Abstract][Full Text] [Related]
4. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
5. Computational probing protein-protein interactions targeting small molecules.
Wang YC; Chen SL; Deng NY; Wang Y
Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
[TBL] [Abstract][Full Text] [Related]
6. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
[TBL] [Abstract][Full Text] [Related]
7. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
8. Guiding Medicinal Chemistry with Fragment Molecular Orbital (FMO) Method.
Heifetz A; James T; Southey M; Bodkin MJ; Bromidge S
Methods Mol Biol; 2020; 2114():37-48. PubMed ID: 32016885
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
Ni D; Lu S; Zhang J
Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
[TBL] [Abstract][Full Text] [Related]
10. A homologous mapping method for three-dimensional reconstruction of protein networks reveals disease-associated mutations.
Huang SH; Lo YS; Luo YC; Tseng YY; Yang JM
BMC Syst Biol; 2018 Mar; 12(Suppl 2):13. PubMed ID: 29560828
[TBL] [Abstract][Full Text] [Related]
11. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
[TBL] [Abstract][Full Text] [Related]
12. Accurate Scoring in Seconds with the Fragment Molecular Orbital and Density-Functional Tight-Binding Methods.
Morao I; Heifetz A; Fedorov DG
Methods Mol Biol; 2020; 2114():143-148. PubMed ID: 32016891
[TBL] [Abstract][Full Text] [Related]
13. Protein-protein interactions: network analysis and applications in drug discovery.
Bultinck J; Lievens S; Tavernier J
Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
[TBL] [Abstract][Full Text] [Related]
14. MEGADOCK-Web: an integrated database of high-throughput structure-based protein-protein interaction predictions.
Hayashi T; Matsuzaki Y; Yanagisawa K; Ohue M; Akiyama Y
BMC Bioinformatics; 2018 May; 19(Suppl 4):62. PubMed ID: 29745830
[TBL] [Abstract][Full Text] [Related]
15. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
[TBL] [Abstract][Full Text] [Related]
16. State of the art in protein-protein interactions within the fungi kingdom.
Santos TG; Silva KS; Lima RM; Silva LC; Pereira M
Future Microbiol; 2023 Nov; 18():1119-1131. PubMed ID: 37540069
[TBL] [Abstract][Full Text] [Related]
17. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
[TBL] [Abstract][Full Text] [Related]
18. PPI-Hotspot
Chen YC; Chen YH; Wright JD; Lim C
J Chem Inf Model; 2022 Feb; 62(4):1052-1060. PubMed ID: 35147037
[TBL] [Abstract][Full Text] [Related]
19. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
[TBL] [Abstract][Full Text] [Related]
20. Allosteric Modulators of Protein-Protein Interactions (PPIs).
Ni D; Liu N; Sheng C
Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
